Henkin Stanislav, Negrotto Sara M, Tweet Marysia S, Kirmani Salman, Deyle David R, Gulati Rajiv, Olson Timothy M, Hayes Sharonne N
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Heart. 2016 Jun 1;102(11):876-81. doi: 10.1136/heartjnl-2015-308645. Epub 2016 Feb 10.
Spontaneous coronary artery dissection (SCAD) is an under-recognised but important cause of myocardial infarction and sudden cardiac death. We sought to determine the role of medical and molecular genetic screening for connective tissue disorders in patients with SCAD.
We performed a single-centre retrospective descriptive analysis of patients with spontaneous coronary artery disease who had undergone medical genetics evaluation 1984-2014 (n=116). The presence or absence of traits suggestive of heritable connective tissue disease was extracted. Genetic testing for connective tissue disorders and/or aortopathies, if performed, is also reported.
Of the 116 patients (mean age 44.2 years, 94.8% women and 41.4% with non-coronary fibromuscular dysplasia (FMD)), 59 patients underwent genetic testing, of whom 3 (5.1%) received a diagnosis of connective tissue disorder: a 50-year-old man with Marfan syndrome; a 43-year-old woman with vascular Ehlers-Danlos syndrome and FMD; and a 45-year-old woman with vascular Ehlers-Danlos syndrome. An additional 12 patients (20.3%) had variants of unknown significance, none of which was thought to be a definite disease-causing mutation based on in silico analyses.
Only a minority of patients with SCAD who undergo genetic evaluation have a likely pathogenic mutation identified on gene panel testing. Even fewer exhibit clinical features of connective tissue disorder. These findings underscore the need for further studies to elucidate the molecular mechanisms of SCAD.
自发性冠状动脉夹层(SCAD)是一种未被充分认识但却是心肌梗死和心源性猝死的重要病因。我们试图确定医学和分子遗传学筛查在SCAD患者结缔组织疾病中的作用。
我们对1984年至2014年接受医学遗传学评估的自发性冠状动脉疾病患者进行了单中心回顾性描述性分析(n = 116)。提取了提示遗传性结缔组织疾病的特征的存在与否。还报告了对结缔组织疾病和/或主动脉病变进行的基因检测(如果进行了检测)。
116例患者(平均年龄44.2岁,94.8%为女性,41.4%患有非冠状动脉纤维肌发育不良(FMD))中,59例患者接受了基因检测,其中3例(5.1%)被诊断为结缔组织疾病:一名50岁患有马凡综合征的男性;一名43岁患有血管性埃勒斯-当洛综合征和FMD的女性;以及一名45岁患有血管性埃勒斯-当洛综合征的女性。另外12例患者(20.3%)有意义未明的变异,根据计算机分析,这些变异均未被认为是明确的致病突变。
在接受基因评估的SCAD患者中,只有少数人在基因检测板检测中发现可能的致病突变。表现出结缔组织疾病临床特征的患者更少。这些发现强调需要进一步研究以阐明SCAD的分子机制。